Each one in plain English, with the numbers worked through for a shareholder.
6 Apr 2022capital raising announcement▲ GoodMajor
Raises A$30M via placement at A$0.13 a share, with one option (A$0.18, expiring March 2025) per two shares; options need shareholder approval. Funds go to land purchase, a Zone 2 extension drill program, by-product testwork and SRK work. Ukraine work is suspended.
Issues 26.3M shares for Millstone's second A$2.5M tranche following AGM approval, plus small debt-settlement shares, option exercises, 21M unlisted options and 80M performance shares to directors Sage, Day and Carter. Routine issue notice, though the director performance shares add potential dilution.
First Millstone tranche completes: A$2.5M received for 26,310,749 shares. Part of the A$20M subscription tied to the Ukraine Petro Consulting acquisition announced in November; A$2.5M more needs AGM approval and A$15M comes on completion of that acquisition.
6M shares issued on conversion of the remaining 300 Winance convertible notes, ending that Tranche 2 drawdown. Routine issue notice; no cash raised is stated.
Completes the 10 August placement: 104M shares issued, plus 2M to lead manager Evolution and 200,000 to settle a A$12,000 debt. Also issued 52M placement options and 20M broker options (7.5c, April 2024). Administrative follow-up with no new facts.
10 Aug 2021capital raising announcement● NeutralMajor
Raises A$6.5M from sophisticated investors at 6.25c per share, with one free 7.5c option (expiring April 2024) per two shares, to fund the DFS. Lead manager Evolution gets 6% fee, 20M options and 2M shares. Chair expects drilling and metallurgy results in September.
Issued 193.65M shares, including 138.1M placement shares and 42.1M Share Purchase Plan shares. The plan was fully subscribed at its A$2M cap and scaled back. Also 12.5M shares from converting 700 Winance notes.
19 Jan 2021capital raising announcement▲ GoodMajor
Secured commitments for a A$7M placement at 5c with one 7.5c option for every two shares, for Wolfsberg, the WA gold tenement and working capital. Evolution Capital and Empire lead it for a 6% fee. Options need shareholder approval.
Offer booklet for the Share Purchase Plan at 4.75c, targeting about A$2M, up to A$30,000 per holder, open 8 October to 3 November. Funds go mainly to exploring the new WA gold tenement E47/4144, plus costs and working capital.
Formal compliance notice for 44,363,643 placement shares issued on 22 September 2020 under existing placement capacity. Administrative; the share count differs from the roughly 46.4M mentioned in the raising announcement.
Completed a placement of about A$2.1M (46.4M shares) at 4.5c, with a 1-for-4 free 5c option expiring July 2022 (needs shareholder approval). Funds go to metallurgical testing and the feasibility study, and to redeem 500 Winance notes for A$636,364.
Talaxis's Kimon Gkomozias joins as Executive Director to drive financing and partner search, while Tim Turner resigns. The company plans a placement of up to A$2M at 4.5c with a 1-for-4 option at 5c expiring July 2022; Empire gets a 6% fee.
27 May 2020capital raising announcement● NeutralMajor
Agreed to convert up to A$742,918 of debts, including director and CEO fees and a short-term loan, into up to 16.5M shares at 4.5c with a free 5c option expiring July 2022. Director portions need shareholder approval. This eases cash pressure.
10 May 2019capital raising announcement● NeutralMajor
Placement mainly to European investors at A$0.09 per share to raise up to €1.5M, for the Wolfsberg DFS. Uses existing placement capacity; shares issued as funds arrive over about three weeks. Priced well below the earlier A$0.225 placement.
Routine cleansing prospectus offering up to 20,000 shares at $0.24 to raise $4,800, to remove trading restrictions on recently issued shares. Compliance step, not a real raise; the text provided does not say which issue prompted it.
What it means for a shareholder
20,000 new shares at $0.240 to raise about $4,800. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Placement heavily oversubscribed: firm commitments for $5M at $0.225 a share, with the extra $1M accepted. About 95% was taken up by European investors. Funds go to understanding Zone 2; shares and options due to be issued 11 December.
Supplementary prospectus extends the offer closing date to 12 December 2017 and details the placement: 17.78M shares at $0.225 (up to 22.2M with oversubscriptions), with free options at $0.25 and 14.4M facilitator options. Shares on issue were 516.1M.
What it means for a shareholder
17.8m new shares at $0.225 to raise about $4.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Placement launched at $0.225 a share to raise up to $4.0M, plus up to $1M in oversubscriptions, a 40% premium to the 15-day average price. Free $0.25 options attach. Funds go to expediting drilling in Zone 2 at Wolfsberg. Earlier raises were at $0.05.
Routine cleansing prospectus offering up to 20,000 shares at $0.12 to raise $2,400, lodged to lift trading restrictions on recently issued shares. Same device used after the October placement; it is a compliance step, not a real raise.
What it means for a shareholder
20,000 new shares at $0.120 to raise about $2,400. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Second and final placement tranche: 13.9M shares at $0.05 raised $695,000, plus 500,000 shares settling $25,000 of debts. Completes the October placement begun on 10 October; this tranche diluted holders by 2.94%.
First tranche of October placement completed: 28.75M shares at $0.05 raised $1,437,500, plus 2.83M shares issued to settle $141,500 owed. Funds are still arriving for the remainder. Total dilution from this tranche is 6.90%.
10 Oct 2017capital raising announcement▲ GoodMajor
Placement of up to $2 million at $0.05 per share, mainly to European sophisticated investors, to fund finishing the Wolfsberg pre-feasibility study. Not underwritten. Priced above the June 2017 placement at $0.045.
Cleansing prospectus offer closed with no shares issued (final number nil, versus up to 20,000 proposed). Administrative close-out of the fix for the defective cleansing notices.
Formal notice that up to 20,000 shares at $0.05 may be issued under the 10 July cleansing prospectus. Administrative step to fix the defective cleansing notices, not a real fundraising.
What it means for a shareholder
20,000 new shares at $0.050 to raise about $1,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Cleansing prospectus offers up to 20,000 shares at $0.05 to raise only $1,000. Its purpose is to remove trading restrictions on shares issued earlier, fixing the defective cleansing notices. Not a real fundraising.
What it means for a shareholder
20,000 new shares at $0.050 to raise about $1,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Placement raising A$1.1M at $0.045 per share, with one $0.05 option (expiring 31 March 2020) for every two shares. Below the $0.08 raised in September 2016. Funds go towards finalising the PFS.